Prostate cancer (Screening)
Prostate Cancer Screening
A recent published study concluded "After 20 years of follow-up the rate of death from prostate cancer did not differ significantly between men in the screening group and those in the control group".
In the United States, the U.S. Food and Drug Administration (FDA) has approved the PSA test for annual screening of prostate cancer in men of age 50 and older. The patient needs to be informed of the risks and benefits of PSA testing prior to performing the test. PSA levels between 4 and 10 ng/mL (nanograms per milliliter) are considered to be suspicious and consideration should be given to confirming the abnormal PSA with a repeat test. If indicated, prostate biopsy is performed to obtain tissue sample for histopathological analysis.
New Non-surgical treatment for Benign Prostatic Hyperplasia (BPH) By Prostatic Artery Embolization (PAE)
Now a new Non-surgical treatment for (BPH) enlarged prostate (not for cancer patient) has been developed which shows better result than open surgeries the technique called Prostatic Artery Embolization (PAE). It can be performed on any size prostate, It does not produce the side effects that TURP does, Whole procedure done through a small nick around the skin in the groin region, Most men experience no pain and leave the hospital in a day after intervention, No sexual dysfunction following prostatic artery embolization and a quarter of patients report that sexual function improved after the procedure. The PAE procedure need just local anesthesia, no blood loss and it makes faster recovery.
Low cost non-surgical treatment of enlarged prostate in Delhi, India as compare to other cities of India like Mumbai, Bangalore, Chennai Ahmedabad, Hyderabad, Pune.
For more in-depth information contact:
Consultant Interventional Radiologist
Mobile or Whatsapp: 098104 92778 or E-mail - firstname.lastname@example.org